Tracing an ancestral mutation: genealogical and haplotype analysis of the infantile onset spinocerebellar ataxia locus.

Infantile onset spinocerebellar ataxia (IOSCA) is a progressive neurological syndrome exhibiting an autosomal recessive pattern of inheritance. The characteristic features were described in Finland in the beginning of 1990s. Having shown that IOSCA does not segregate with any of the markers linked to other hereditary ataxias and thus represents a genetically distinct disease, we assigned the locus of this new hereditary ataxia to 10q23.3-q24.1. To approximate the age of the Finnish IOSCA mutation and to investigate the possible existence of more than one mutation underlying the disease, the ancestors of 13 IOSCA families were identified by use of church records dating back to the 1500s. The IOSCA pedigrees were frequently merged, providing support for these having one common ancestor. Analysis of the extended IOSCA haplotypes exposed ancient recombination events and revealed one core haplotype of four markers on a region of approximately 2 cM, which was unequivocally present in 92% of disease chromosomes. Both genealogical and haplotype data thus suggest that a single IOSCA ancestral mutation was introduced into the Finnish population most probably approximately 30-40 generations ago before the time when the general east-west migration took place within Finland.

[1]  L. Peltonen,et al.  Genetic homogeneity of autoimmune polyglandular disease type I. , 1996, American journal of human genetics.

[2]  L. Peltonen,et al.  The age of human mutation: genealogical and linkage disequilibrium analysis of the CLN5 mutation in the Finnish population. , 1996, American journal of human genetics.

[3]  L. Peltonen,et al.  Messages from an isolate: lessons from the Finnish gene pool. , 1995, Biological chemistry Hoppe-Seyler.

[4]  L. Peltonen,et al.  Random search for shared chromosomal regions in four affected individuals: the assignment of a new hereditary ataxia locus. , 1995, American journal of human genetics.

[5]  L. Peltonen,et al.  Identification of a novel mutation causing aspartylglucosaminuria reveals a mutation hotspot region in the aspartylglucosaminidase gene , 1995, Human mutation.

[6]  L. Peltonen,et al.  Infantile Onset Spinocerebellar Ataxia Represents an Allelic Disease Distinct from Other Hereditary Ataxias , 1994, Pediatric Research.

[7]  L. Peltonen,et al.  Defined chromosomal assignment of CLN5 demonstrates that at least four genetic loci are involved in the pathogenesis of human ceroid lipofuscinoses. , 1994, American journal of human genetics.

[8]  L. Peltonen,et al.  An autosomal locus causing autoimmune disease: autoimmune polyglandular disease type I assigned to chromosome 21 , 1994, Nature Genetics.

[9]  Cécile Fizames,et al.  The 1993–94 Généthon human genetic linkage map , 1994, Nature Genetics.

[10]  A. Paetau,et al.  Sensory neuropathy in infantile onset spinocerebellar ataxia (IOSCA) , 1994, Muscle & nerve.

[11]  K. Sainio,et al.  Infantile onset spinocerebellar ataxia with sensory neuropathy: A new inherited disease , 1994, Journal of the Neurological Sciences.

[12]  A. Chapelle,et al.  Disease gene mapping in isolated human populations: the example of Finland. , 1993, Journal of medical genetics.

[13]  E. Lander,et al.  Localization of the EPM1 gene for progressive myoclonus epilepsy on chromosome 21: linkage disequilibrium allows high resolution mapping. , 1993, Human molecular genetics.

[14]  Eric Lander,et al.  Linkage disequilibrium mapping in isolated founder populations: diastrophic dysplasia in Finland , 1992, Nature Genetics.

[15]  L. Peltonen,et al.  Aspartylglucosaminuria: cDNA encoding human aspartylglucosaminidase and the missense mutation causing the disease. , 1991, The EMBO journal.

[16]  D. Shibata,et al.  Detection of human papilloma virus in paraffin-embedded tissue using the polymerase chain reaction , 1988, The Journal of experimental medicine.

[17]  J. Perheentupa,et al.  Hereditary diseases in Finland; rare flora in rare soul. , 1973, Annals of clinical research.